Education
About Us
Working with TipRanks
Follow Us
Crispr Therapeutics (CRSP)
NASDAQ:CRSP
CRSP Analyst Ratings
Moderate Buy
12 Buy
7 Hold
0 Sell
TipRanks enables you to focus on the analyst rating consensus of all analysts or only the top performers in the past 3 months
CRSP Stock 12 Month Forecast
Average Price Target
$70.06
▲(23.54% Upside)
| Highest Price Target$105.00 | Average Price Target$70.06 | Lowest Price Target$40.00 |
The highest, average, and lowest price target of all analysts. Click on ‘Top Analysts’ to focus on the best performers.
Detailed List of Analyst Forecasts
Detailed List of Analyst Forecasts
Needham
$80
Buy
41.07%
Upside
Reiterated
12/23/25
William Blair
Buy
―
Reiterated
12/22/25
Bank of America Securities
$93
Buy
63.99%
Upside
Reiterated
12/22/25
H.C. Wainwright
$80
Buy
41.07%
Upside
Reiterated
12/10/25
Piper Sandler
$105
Buy
85.15%
Upside
Reiterated
12/08/25
Bernstein
$43
Hold
-24.18%
Downside
Reiterated
12/01/25
Chardan Capital
$74
Buy
30.49%
Upside
Reiterated
11/25/25
Citi
$87→$77
Buy
35.78%
Upside
Reiterated
11/12/25
Truist Financial
Buy
―
Reiterated
11/11/25
Clear Street
$52→$50
Hold
-11.83%
Downside
Reiterated
11/11/25
Barclays
$56
Hold
-1.25%
Downside
Reiterated
11/11/25
J.P. Morgan
$70→$69
Buy
21.67%
Upside
Reiterated
11/11/25
Robert W. Baird
$52→$44
Hold
-22.41%
Downside
Reiterated
11/11/25
TD Cowen
$40
Hold
-29.47%
Downside
Reiterated
11/10/25
Analyst Type
Any
Ranks
Any
Analyst Rating
Any
Upside/ Downside
Any
Action
Any
Needham
$80
Buy
41.07%
Upside
Reiterated
12/23/25
William Blair
Buy
―
Reiterated
12/22/25
Bank of America Securities
$93
Buy
63.99%
Upside
Reiterated
12/22/25
H.C. Wainwright
$80
Buy
41.07%
Upside
Reiterated
12/10/25
Piper Sandler
$105
Buy
85.15%
Upside
Reiterated
12/08/25
Bernstein
$43
Hold
-24.18%
Downside
Reiterated
12/01/25
Chardan Capital
$74
Buy
30.49%
Upside
Reiterated
11/25/25
Citi
$87→$77
Buy
35.78%
Upside
Reiterated
11/12/25
Truist Financial
Buy
―
Reiterated
11/11/25
Clear Street
$52→$50
Hold
-11.83%
Downside
Reiterated
11/11/25
Barclays
$56
Hold
-1.25%
Downside
Reiterated
11/11/25
J.P. Morgan
$70→$69
Buy
21.67%
Upside
Reiterated
11/11/25
Robert W. Baird
$52→$44
Hold
-22.41%
Downside
Reiterated
11/11/25
TD Cowen
$40
Hold
-29.47%
Downside
Reiterated
11/10/25
Best Analysts Covering Crispr Therapeutics AG
1 Month
xxx
Success Rate
13/22 ratings generated profit
Average Return
+8.54%
reiterated a xxx
rating 2 months ago
Copying xxxxxxxxxxxxxxxxxx
trades and holding each position for 1 Month would result in 59.09% of your transactions generating a profit, with an average return of +8.54% per trade.
3 Months
xxx
Success Rate
13/22 ratings generated profit
Average Return
+7.66%
reiterated a xxx
rating 2 months ago
Copying xxxxxxxxxxxxxxxxxx
trades and holding each position for 3 Months would result in 59.09% of your transactions generating a profit, with an average return of +7.66% per trade.
1 Year
Success Rate
12/22 ratings generated profit
Average Return
+8.65%
reiterated a buy rating 2 months ago
Copying Mani Foroohar's trades and holding each position for 1 Year would result in 54.55% of your transactions generating a profit, with an average return of +8.65% per trade.
2 Years
xxx
Success Rate
12/22 ratings generated profit
Average Return
+4.45%
reiterated a xxx
rating 2 months ago
Copying xxxxxxxxxxxxxxxxxx
trades and holding each position for 2 Years would result in 54.55% of your transactions generating a profit, with an average return of +4.45% per trade.
The Best Analyst Covering tool allows you to follow the analysts who have the best success rates and average returns on a specific stock. Only analysts that gave a Buy or Sell rating on the stock in the past 12 months are eligible for inclusion in this tool. Follow the analysts of your choice to receive real-time updates when they publish a new rating.
CRSP Analyst Recommendation Trends
Rating
Aug 25
Sep 25
Oct 25
Nov 25
Dec 25
Strong Buy
9
2
2
4
7
Buy
12
12
18
20
18
Hold
19
14
12
10
9
Sell
0
0
0
1
1
Strong Sell
0
0
0
0
0
total
40
28
32
35
35
Each month's total comprises the sum of three months' worth of ratings.
CRSP Financial Forecast
CRSP Stock Forecast FAQ
What is CRSP’s average 12-month price target, according to analysts?
Based on analyst ratings, Crispr Therapeutics’s 12-month average price target is 70.06.
What is CRSP’s upside potential, based on the analysts’ average price target?
Crispr Therapeutics has 23.54% upside potential, based on the analysts’ average price target.
Can I see which stocks the top-ranking analysts are rating?
Yes, go to the Analysts’ Top Stocks tool to see stocks with a Strong Buy or Strong Sell analyst rating consensus, according to the top performers.
How can I follow the stock ratings of top Wall Street analysts?
Head over to our Expert Center to see a list of the top 100 Wall Street analysts and follow the analysts of your choice. Visit their profiles for more details about their stock ratings and see how they perform on a stock-by-stock basis.
Is CRSP a Buy, Sell or Hold?
Crispr Therapeutics has a consensus rating of Moderate Buy which is based on 12 buy ratings, 7 hold ratings and 0 sell ratings.
What is Crispr Therapeutics’s price target?
The average price target for Crispr Therapeutics is 70.06. This is based on 19 Wall Streets Analysts 12-month price targets, issued in the past 3 months.
The highest analyst price target is $105.00 ,the lowest forecast is $40.00. The average price target represents 23.54% Increase from the current price of $56.71.
The highest analyst price target is $105.00 ,the lowest forecast is $40.00. The average price target represents 23.54% Increase from the current price of $56.71.
What do analysts say about Crispr Therapeutics?
Crispr Therapeutics’s analyst rating consensus is a Moderate Buy. This is based on the ratings of 19 Wall Streets Analysts.
How can I buy shares of CRSP?
Open a brokerage account, see exclusive account opening deals on our Best Online Brokers page.